Comprehensive analysis of loops at protein-protein interfaces for macrocycle design

Nature Chemical Biology

Volumn 10, Issue 9, 2014, Pages 716-722

  Gavenonis, Jason ^a   Sheneman, Bradley A ^a   Siegert, Timothy R ^a   Eshelman, Matthew R ^a   Kritzer, Joshua A ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROCYCLIC COMPOUND;

ARTICLE; DATA BASE; MOLECULAR BIOLOGY; MOLECULAR MIMICRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

ALANINE; DATABASES, FACTUAL; DATABASES, PROTEIN; DRUG DESIGN; MACROCYCLIC COMPOUNDS; MODELS, MOLECULAR; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY;

EID: 84906327241     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.1580     Document Type: Article

References (44)

1. Wells, J.A. & McClendon, C.L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450, 1001-1009 (2007).
2. Marsault, E. & Peterson, M.L. Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery. J. Med. Chem. 54, 1961-2004 (2011).
3. Bock, J.E., Gavenonis, J. & Kritzer, J.A. Getting in shape: controlling peptide bioactivity and bioavailability using conformational constraints. ACS Chem. Biol. 8, 488-499 (2013).
4. Vagner, J., Qu, H. & Hruby, V.J. Peptidomimetics, a synthetic tool of drug discovery. Curr. Opin. Chem. Biol. 12, 292-296 (2008).
5. Nowick, J.S. Exploring β-sheet structure and interactions with chemical model systems. Acc. Chem. Res. 41, 1319-1330 (2008).
6. Azzarito, V., Long, K., Murphy, N.S. & Wilson, A.J. Inhibition of α-helix-mediated protein-protein interactions using designed molecules. Nat. Chem. 5, 161-173 (2013).
7. Guharoy, M. & Chakrabarti, P. Secondary structure based analysis and classification of biological interfaces: identification of binding motifs in protein-protein interactions. Bioinformatics 23, 1909-1918 (2007).
8. Guney, E., Tuncbag, N., Keskin, O. & Gursoy, A. HotSprint: database of computational hot spots in protein interfaces. Nucleic Acids Res. 36, D662-D666 (2008).
9. Koes, D. et al. Enabling large-scale design, synthesis and validation of small molecule protein-protein antagonists. PLoS ONE 7, e32839 (2012).
10. Jochim, A.L. & Arora, P.S. Systematic analysis of helical protein interfaces reveals targets for synthetic inhibitors. ACS Chem. Biol. 5, 919-923 (2010).
11. Bergey, C.M., Watkins, A.M. & Arora, P.S. HippDB: a database of readily targeted helical protein-protein interactions. Bioinformatics 29, 2806-2807 (2013).
12. London, N., Raveh, B., Movshovitz-Attias, D. & Schueler-Furman, O. Can self-inhibitory peptides be derived from the interfaces of globular protein-protein interactions? Proteins 78, 3140-3149 (2010).
13. Chrencik, J.E. et al. Structure and thermodynamic characterization of the EphB4/ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity. Structure 14, 321-330 (2006).
14. Kortemme, T. & Baker, D. A simple physical model for binding energy hot spots in protein-protein complexes. Proc. Natl. Acad. Sci. USA 99, 14116-14121 (2002).
15. Kortemme, T., Kim, D. & Baker, D. Computational alanine scanning of protein-protein interfaces. Sci. STKE 2004, pl2 (2004).
16. Chaudhury, S., Lyskov, S. & Gray, J.J. PyRosetta: a script-based interface for implementing molecular modeling algorithms using Rosetta. Bioinformatics 26, 689-691 (2010).
17. Shulman-Peleg, A., Shatsky, M., Nussinov, R. & Wolfson, H.J. Spatial chemical conservation of hot spot interactions in protein-protein complexes. BMC Biol. 5, 43 (2007).
18. Golovin, A. & Henrick, K. MSDmotif: exploring protein sites and motifs. BMC Bioinformatics 9, 312 (2008).
19. Bogan, A.A. & Thorn, K.S. Anatomy of hot spots in protein interfaces. J. Mol. Biol. 280, 1-9 (1998).
20. Janin, J., Miller, S. & Chothia, C. Surface, subunit interfaces and interior of oligomeric proteins. J. Mol. Biol. 204, 155-164 (1988).
21. Tsai, C.-J., Lin, S.L., Wolfson, H.J. & Nussinov, R. Studies of protein-protein interfaces: a statistical analysis of the hydrophobic effect. Protein Sci. 6, 53-64 (1997).
22. Cunningham, B.C. & Wells, J.A. Rational design of receptor-specific variants of human growth hormone. Proc. Natl. Acad. Sci. USA 88, 3407-3411 (1991).
23. Cunningham, B.C. & Wells, J.A. Comparison of a structural and a functional epitope. J. Mol. Biol. 234, 554-563 (1993).
24. Sundström, M. et al. Crystal structure of an antagonist mutant of human growth hormone, G120R, in complex with its receptor at 2.9 A resolution. J. Biol. Chem. 271, 32197-32203 (1996).
25. Hong, D.S. et al. A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas. Clin. Cancer Res. 18, 3396-3406 (2012).
26. Lo, S.-C., Li, X., Henzl, M.T., Beamer, L.J. & Hannink, M. Structure of the Keap1: Nrf2 interface provides mechanistic insight into Nrf2 signaling. EMBO J. 25, 3605-3617 (2006).
27. Chen, Y., Inoyama, D., Kong, A.-N.T., Beamer, L.J. & Hu, L. Kinetic analyses of Keap1-Nrf2 interaction and determination of the minimal Nrf2 peptide sequence required for Keap1 binding using surface plasmon resonance. Chem. Biol. Drug Des. 78, 1014-1021 (2011).
28. Hancock, R., Schaap, M., Pfister, H. & Wells, G. Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity. Org. Biomol. Chem. 11, 3553-3557 (2013).
29. Hörer, S., Reinert, D., Ostmann, K., Hoevels, Y. & Nar, H. Crystal-contact engineering to obtain a crystal form of the Kelch domain of human Keap1 suitable for ligand-soaking experiments. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 69, 592-596 (2013).
30. Chen, Q. et al. Targeting the p27 E3 ligase SCFSkp2 results in p27-and Skp2-mediated cell-cycle arrest and activation of autophagy. Blood 111, 4690-4699 (2008).
31. Hao, B. et al. Structural basis of the Cks1-dependent recognition of p27Kip1 by the SCFSkp2 ubipuitin ligase. Mol. Cell 20, 9-19 (2005).
32. Sitry, D. et al. Three different binding sites of Cks1 are required for p27-ubiquitin ligation. J. Biol. Chem. 277, 42233-42240 (2002).
33. Huang, K.S. & Vassilev, L.T. High-throughput screening for inhibitors of the Cks1-Skp2 interaction. Methods Enzymol. 399, 717-728 (2005).
34. Ungermannova, D. et al. High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1. J. Biomol. Screen. 18, 910-920 (2013).
35. Wu, L. et al. Specific small molecule inhibitors of Skp2-mediated p27 degradation. Chem. Biol. 19, 1515-1524 (2012).
36. Huang, J. et al. Structural insight into the regulation of MOF in the male-specific lethal complex and the non-specific lethal complex. Cell Res. 22, 1078-1081 (2012).
37. Kadlec, J. et al. Structural basis for MOF and MSL3 recruitment into the dosage compensation complex by MSL1. Nat. Struct. Mol. Biol. 18, 142-149 (2011).
38. Clackson, T. & Wells, J. A hot spot of binding energy in a hormone-receptor interface. Science 267, 383-386 (1995).
39. DeLano, W.L. Unraveling hot spots in binding interfaces: progress and challenges. Curr. Opin. Struct. Biol. 12, 14-20 (2002).
40. Gohlke, H., Kiel, C. & Case, D.A. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J. Mol. Biol. 330, 891-913 (2003).
41. Moreira, I.S., Fernandes, P.A. & Ramos, M.J. Hot spots-a review of the protein-protein interface determinant amino-acid residues. Proteins 68, 803-812 (2007).
42. DeLano, W.L. The PyMOL Molecular Graphic System, Version 0.99 (DeLano Scientific LLC, 2006).
43. Wisniewska, M. et al. Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex. J. Mol. Biol. 381, 1307-1319 (2008).
44. Fersht, A.R. et al. Hydrogen bonding and biological specificity analysed by protein engineering. Nature 314, 235-238 (1985).